期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 22, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/ijms22031422
关键词
transcriptomics; RNA; cancer; oncogenesis; personalized medicine
资金
- Statutory Subsidy Funds of the Genetics Department, Wroclaw Medical University [SUB.A.290.19.020]
Transcriptome profiling has emerged as a powerful approach in oncology, providing prognostic and predictive utility for cancer management. It enables the identification of cancer biomarkers, gene signatures, and molecular targets for anticancer therapies, contributing to a change in the holistic understanding of cancer from histopathological to molecular classifications. Further advancements in transcriptome profiling may lead to standardization and cost reduction of its analysis, making it a canon of contemporary cancer medicine.
Over the last decades, transcriptome profiling emerged as one of the most powerful approaches in oncology, providing prognostic and predictive utility for cancer management. The development of novel technologies, such as revolutionary next-generation sequencing, enables the identification of cancer biomarkers, gene signatures, and their aberrant expression affecting oncogenesis, as well as the discovery of molecular targets for anticancer therapies. Transcriptomics contribute to a change in the holistic understanding of cancer, from histopathological and organic to molecular classifications, opening a more personalized perspective for tumor diagnostics and therapy. The further advancement on transcriptome profiling may allow standardization and cost reduction of its analysis, which will be the next step for transcriptomics to become a canon of contemporary cancer medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据